Persistent neutralizing antibodies abolish the interferon beta bioavailability in MS patients.

MLA

Bertolotto, A., et al. “Persistent Neutralizing Antibodies Abolish the Interferon Beta Bioavailability in MS Patients.” Neurology, vol. 60, no. 4, Feb. 2003, pp. 634–39. EBSCOhost, https://doi.org/10.1212/01.wnl.0000046662.03894.c5.

APA

Bertolotto, A., Gilli, F., Sala, A., Capobianco, M., Malucchi, S., Milano, E., Melis, F., Marnetto, F., Lindberg, R. L. P., Bottero, R., Di Sapio, A., & Giordana, M. T. (2003). Persistent neutralizing antibodies abolish the interferon beta bioavailability in MS patients. Neurology, 60(4), 634–639. https://doi.org/10.1212/01.wnl.0000046662.03894.c5

Chicago

Bertolotto, A, F Gilli, A Sala, M Capobianco, S Malucchi, E Milano, F Melis, et al. 2003. “Persistent Neutralizing Antibodies Abolish the Interferon Beta Bioavailability in MS Patients.” Neurology 60 (4): 634–39. doi:10.1212/01.wnl.0000046662.03894.c5.